Group structure
7 companies in 6 countries
Loading your page…
Loading your page…
7 companies in 6 countries
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine of every company in the group, current ones first.
9 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| Amvuttra solution for injection in pre-filled syringe 25mg25mg · Injection, solution | Vutrisiran | Singapore | Authorised | 2024 |
| BYLVAY1200 mcg · Capsule | Odevixibat | Canada | Marketed | 2024 |
| BYLVAY400 mcg · Capsule | Odevixibat | Canada | Marketed | 2024 |
| BYLVAY600 mcg · Capsule | Odevixibat | Canada | Marketed | 2024 |
| BYLVAY200 mcg · Capsule | Odevixibat | Canada | Marketed | 2024 |
| KIMMTRAK | Tebentafusp | Brazil | Authorised | 2025 |
| KIMMTRAK100mcg/0.5mL · koncentrat za rastvor za infuziju | Tebentafusp | Serbia | Authorised | 2023 |
| TAVALISSE150 mg · Tablet | Fostamatinib | Canada | Marketed | 2020 |
| TAVALISSE100 mg · Tablet | Fostamatinib | Canada | Marketed | 2020 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Canada | 6 | 6 | 0 | CompaniesAll medicines |
| Brazil | 1 | 1 | 0 | CompaniesAll medicines |
| Serbia | 1 | 1 | 0 | CompaniesAll medicines |
| Singapore | 1 | 1 | 0 | CompaniesAll medicines |
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.
ANVISA / CMED, consumer price table; embedded source date 2026-07-21 and retrieval date
Licence: Other (Public Domain)
Anvisa published factual open-data CSV https://dados.anvisa.gov.br/dados/CONSULTAS/PRODUTOS/TA_CONSULTA_MEDICAMENTOS.CSV, HTTP version Mon, 12 Oct 2026 11:45:25 GMT; acquired 12 October 2026; original source states and timestamps retained.
Licence: Brazil federal factual open data, consolidated Decreto 8777/2016 article 4; attribution and third-party exceptions
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licence: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
ALIMS, Registar humanih lekova, source 08.10.2026 02:00, downloaded 2026-10-08, https://data.gov.rs/sr/datasets/lekovi-za-upotrebu-u-khumanoj-meditsini/; structured factual adaptation; Serbian Open Data Licence.
Licence: Serbian Open Data Licence (sodl)
Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence
Licence: Singapore Open Data Licence
Report an error or request removalCorrections from the company itself are welcome.
Well-known pharmaceutical groups, each with all its companies.